Human HCT116 Red-FLuc Reporter Tumor Cell Line(CAT#: NTCC-CBO012)肿瘤细胞株-BioVector NTCC保藏中心

DescriptionThe HCT116-Red-FLuc cell line is a luminescent cell line derived from HCT116 human colorectal cancer. The cells have been stably transduced with the red-shifted firefly luciferase gene (Red-FLuc), resulting in a brighter, red-shifted cell signal. By emitting enhanced light of longer wavelengths that are significantly brighter than other firefly luciferases, our bioluminescent tumor cell line allows you to visualize and monitor the growth of deep tissue tumors in vivo. After the cells are injected into a suitable mouse model, the optimized Red-FLuc luciferase can achieve more sensitive in vivo optical detection with less tissue attenuation, so you can detect tumor development earlier and subcutaneously monitor tumor growth and metastasis in the orthotopic model. FeaturesOur bioluminescent tumor cell line is labeled with Red-Fluc or dual labeled with a fluorescent reporter (GFP). These red-shifted tumor cell lines are significantly brighter than other firefly luciferases (10-20 times brighter in vitro). Creative Biolabs' cell line is bright enough to measure tumor growth in the in vivo optical imaging system immediately after injection, much earlier than the time when the tumor can be touched, so you can start at a point in time that cannot be measured with a traditional micrometer data collection. Our tumor cell lines cover a variety of cancer models, including breast cancer, colorectal cancer, prostate cancer, lung cancer, lymphoma, etc. ApplicationsIn Vivo Imaging OrganismHuman Strain NameHCT116 TissueColon DiseaseColorectal Carcinoma Optical ReporterRed-FLuc